Plain-English translation of NCT06676657 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the iPancreas automated insulin delivery system, a smart insulin pump that works with a continuous glucose monitor and activity watch to automatically adjust your insulin doses. During the first 3 weeks, the system learns your personal patterns—when your blood sugar tends to rise and why. After that, the system turns on a special feature that detects high blood sugar patterns and adjusts your insulin automatically to prevent them.
Current insulin pumps require frequent manual adjustments, and people with type 1 diabetes still experience high blood sugar episodes. This trial aims to see if a system that learns your individual patterns can prevent high blood sugar more effectively than standard automated pumps.
You likely qualify if…
You likely don't qualify if…
You will wear the iPancreas system (including an Omnipod insulin pump, Dexcom glucose monitor, and activity watch) for 4 weeks at home. You'll come to the clinic on Day 1 for training, then spend the first 3 weeks in your normal routine so the system can learn your patterns. After a virtual check-in, the system turns on its pattern-detection feature for the final week, and you'll complete some meal and exercise challenges to test how well it works.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States